| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | Chief Financial Officer | Common Stock | 313K | $154K | $0.49 | Feb 16, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | Feb 16, 2023 | 1 | -$30.8K | 4 | Feb 17, 2023 | Chief Financial Officer |
| NKTR | NEKTAR THERAPEUTICS | Nov 16, 2022 | 1 | -$39.6K | 4 | Nov 18, 2022 | Chief Financial Officer |
| NKTR | NEKTAR THERAPEUTICS | Aug 15, 2022 | 3 | -$9.55K | 4 | Aug 17, 2022 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | May 15, 2022 | 2 | -$23.1K | 4 | May 17, 2022 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | Feb 16, 2022 | 1 | -$25.9K | 4 | Feb 18, 2022 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | Dec 16, 2021 | 2 | $0 | 4 | Dec 20, 2021 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | Nov 15, 2021 | 2 | -$88.7K | 4 | Nov 17, 2021 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | Oct 12, 2021 | 1 | $0 | 4 | Oct 14, 2021 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | Aug 16, 2021 | 1 | -$184K | 4 | Aug 18, 2021 | SVP & Chief Accounting Officer |
| NKTR | NEKTAR THERAPEUTICS | May 17, 2021 | 1 | -$245K | 4 | May 19, 2021 | SVP & Chief Accounting Officer |